The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Impairment of Endothelial Functions by Acute Hyperhomocysteinemia and Reversal by Antioxidant Vitamins
Abstract
CONTEXT: Increased levels of homocysteine are associated with risk of cardiovascular disease. Homocysteine may cause this risk by impairing endothelial cell function. OBJECTIVE: To evaluate the effect of acute hyperhomocysteinemia with and without antioxidant vitamin pretreatment on cardiovascular risk factors and endothelial functions. DESIGN AND SETTING: Observer-blinded, randomized crossover study conducted at a university hospital in Italy. SUBJECTS: Twenty healthy hospital staff volunteers (10 men, 10 women) aged 25 to 45 years. INTERVENTIONS: Subjects were given each of 3 loads in random order at 1-week intervals: oral methionine, 100 mg/kg in fruit juice; the same methionine load immediately following ingestion of antioxidant vitamin E, 800 IU, and ascorbic acid, 1000 mg; and methionine-free fruit juice (placebo). Ten of the 20 subjects also ingested a placebo load with vitamins. MAIN OUTCOME MEASURES: Lipid, coagulation, glucose, and circulating adhesion molecule parameters, blood pressure, and endothelial functions as assessed by hemodynamic and rheologic responses to L-arginine, evaluated at baseline and 4 hours following ingestion of the loads. RESULTS: The oral methionine load increased mean (SD) plasma homocysteine level from 10.5 (3.8) micromol/L at baseline to 27.1 (6.7) micromol/L at 4 hours (P<.001). A similar increase was observed with the same load plus vitamins (10.0 [4.0] to 22.7 [7.8] micromol/L; P<.001) but no significant increase was observed with placebo (10.1 [3.7] to 10.4 [3.2] micromol/L; P=.75). Coagulation and circulating adhesion molecule levels significantly increased after methionine ingestion alone (P<.05) but not after placebo or methionine ingestion with vitamins. While the mean (SD) blood pressure (-7.0% [2.7%]; P<.001), platelet aggregation response to adenosine diphosphate (-11.4% [4.5%]; P=.009) and blood viscosity (-3.0% [1.2%]; P=.04) declined in these parameters 10 minutes after an L-arginine load (3 g) following placebo, the increase after methionine alone (-2.3% [1.5%], 4.0% [3.0%], and 1.5% [1.0%], respectively; P<.05), did not occur following methionine load with vitamin pretreatment (-6.3% [2.5%], -7.9% [3.5%], and -1.5% [1.0%], respectively; P=.24). CONCLUSION: Our data suggest that mild to moderate elevations of plasma homocysteine levels in healthy subjects activate coagulation, modify the adhesive properties of endothelium, and impair the vascular responses to L-arginine. Pretreatment with antioxidant vitamin E and ascorbic acid blocks the effects of hyperhomocysteinemia, suggesting an oxidative mechanism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The L-Arginine-Nitric Oxide Pathway
Epstein, F. H., Moncada, S., & Higgs, A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292706 · Cited by 6,678
Boushey, C. J. (1995) · JAMA · doi:10.1001/jama.1995.03530130055028 · Cited by 3,584
Hyperhomocysteinemia: An Independent Risk Factor for Vascular Disease
Clarke, R., Daly, L., Robinson, K., Naughten, E., Cahalane, S., Fowler, B., & Graham, I. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104253241701 · Cited by 2,161
Close Relation of Endothelial Function in the Human Coronary and Peripheral Circulations
Anderson, T. J., Uehata, A., Gerhard, M. D., Meredith, I. T., Knab, S., Delagrange, D., Lieberman, E. H., Ganz, P., Creager, M. A., Yeung, A. C., et al. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00327-4 · Cited by 2,033 · cited 1×
“Endothelial dysfunction, when present, tends to be generalized; a close relationship has been demonstrated between endothelial function in human peripheral and coronary circulation.(34)”
BackgroundAscorbate is an outstanding antioxidant in human blood plasma
Frei, B., England, L., & Ames, B. N. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.16.6377 · Cited by 1,870
Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo
Rees, D. D., Palmer, R. M. J., Schulz, R., Hodson, H. F., & Moncada, S. (1990) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1990.tb14151.x · Cited by 1,856
Basic and Clinical Biostatistics,
(2002) · Survey of Ophthalmology · doi:10.1016/s0039-6257(02)00360-0 · Cited by 1,809
Plasma Homocysteine Levels and Mortality in Patients with Coronary Artery Disease
Nygård, O., Nordrehaug, J. E., Refsum, H., Ueland, P. M., Farstad, M., & Vollset, S. E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707243370403 · Cited by 1,756
Plasma Homocysteine as a Risk Factor for Vascular Disease: The European Concerted Action Project
Graham, I. M. (1997) · JAMA · doi:10.1001/jama.1997.03540460039030 · Cited by 1,738
A Prospective Study of Plasma Homocyst(e)ine and Risk of Myocardial Infarction in US Physicians
Stampfer, M. J. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03490070059042 · Cited by 1,709
Joannides, R., Haefeli, W. E., Linder, L., Richard, V., Bakkali, E. H., Thuillez, C., & Lüscher, T. F. (1995) · Circulation · doi:10.1161/01.cir.91.5.1314 · Cited by 1,622
Ridker, P. M., Hennekens, C. H., Roitman-Johnson, B., Stampfer, M. J., & Allen, J. (1998) · The Lancet · doi:10.1016/s0140-6736(97)09032-6 · Cited by 1,229 · cited 1×
“Soluble forms of cellular adhesion molecules found in plasma are considered an index of endothelial activation and even a molecular marker of early atherosclerosis.(26)”
BackgroundCelermajer, D. S., Sorensen, K. E., Bull, C., Robinson, J., & Deanfield, J. E. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90141-4 · Cited by 1,229
Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery Stenosis
Selhub, J., Jacques, P. F., Bostom, A. G., D'Agostino, R. B., Wilson, P. W. F., Belanger, A. J., O'Leary, D. H., Wolf, P. A., Schaefer, E. J., & Rosenberg, I. H. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502023320502 · Cited by 1,216
Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease.
Vita, J. A., Treasure, C. B., Nabel, E. G., McLenachan, J. M., Fish, R. D., Yeung, A. C., Vekshtein, V. I., Selwyn, A. P., & Ganz, P. (1990) · Circulation · doi:10.1161/01.cir.81.2.491 · Cited by 1,173
Stamler, J. S., Osborne, J. A., Jaraki, O., Rabbani, L. E., Mullins, M., Singel, D., & Loscalzo, J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116187 · Cited by 860
Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine.
Starkebaum, G., & Harlan, J. M. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112442 · Cited by 822
The oxidant stress of hyperhomocyst(e)inemia.
Loscalzo, J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118776 · Cited by 717
Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum
Ubbink, J. B., Hayward Vermaak, W. J., & Bissbort, S. (1991) · Journal of Chromatography B: Biomedical Sciences and Applications · doi:10.1016/0378-4347(91)80407-4 · Cited by 678
The Endothelium: Modulator of Cardiovascular Function
Lüscher, T. F., & Vanhoutte, P. M. (2020) · CRC Press eBooks · doi:10.1201/9780429281808 · Cited by 527
Robinson, K., Mayer, E. L., Miller, D. P., Green, R., van Lente, F., Gupta, A., Kottke-Marchant, K., Savon, S. R., Selhub, J., Nissen, S. E., et al. (1995) · Circulation · doi:10.1161/01.cir.92.10.2825 · Cited by 390
Homocyst(e)ine and Risk of Cardiovascular Disease in the Multiple Risk Factor Intervention Trial
Evans, R. W., Shaten, B. J., Hempel, J. D., Cutler, J. A., & Kuller, L. H. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.10.1947 · Cited by 342
Bellamy, M. F., McDowell, I. F. W., Ramsey, M. W., Brownlee, M., Bones, C., Newcombe, R. G., & Lewis, M. J. (1998) · Circulation · doi:10.1161/01.cir.98.18.1848 · Cited by 336
Malinow, M. R., Nieto, F. J., Kruger, W. D., Duell, P. B., Hess, D. L., Gluckman, R. A., Block, P. C., Holzgang, C. R., Anderson, P. H., Seltzer, D., et al. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.6.1157 · Cited by 268
Hyperhomocyst(e)inemia. A common and easily reversible risk factor for occlusive atherosclerosis.
Malinow, M. R. (1990) · Circulation · doi:10.1161/01.cir.81.6.2004 · Cited by 253
Oxidation of low density lipoprotein by thiols: superoxide-dependent and -independent mechanisms.
Heinecke, J. W., Kawamura, M., Suzuki, L., & Chait, A. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)35347-5 · Cited by 214
Acute hyperhomocysteinaemia and endothelial dysfunction
Chambers, J. C., McGregor, A., Jean-Marie, J., & Kooner, J. S. (1998) · The Lancet · doi:10.1016/s0140-6736(05)78090-9 · Cited by 208
Atherosclerosis: Risk factors and the vascular endothelium
Glasser, S. P., Selwyn, A. P., & Ganz, P. (1996) · American Heart Journal · doi:10.1016/s0002-8703(96)90370-1 · Cited by 190
Bostom, A. G., Jacques, P. F., Nadeau, M. R., Williams, R. R., Ellison, R. C., & Selhub, J. (1995) · Atherosclerosis · doi:10.1016/0021-9150(95)05529-6 · Cited by 168
Preventing Coronary Heart Disease: B Vitamins and Homocysteine
Omenn, G. S., Beresford, S. A. A., & Motulsky, A. G. (1998) · Circulation · doi:10.1161/01.cir.97.5.421 · Cited by 167
The vascular effects of L-Arginine in humans. The role of endogenous insulin.
Giugliano, D., Marfella, R., Verrazzo, G., Acampora, R., Coppola, L., Cozzolino, D., & D'Onofrio, F. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119177 · Cited by 159
Cytoprotective effects of nitric oxide.
Cooke, J. P., & Tsao, P. S. (1993) · Circulation · doi:10.1161/01.cir.88.5.2451 · Cited by 152
Bode‐Böger, S. M., Böger, R. H., Creutzig, A., Tsikas, D., Gutzki, F. M., Alexander, K. G., & Frölich, J. C. (1994) · Clinical Science · doi:10.1042/cs0870303 · Cited by 146
Seiler, C. A., Hess, O. M., Buechi, M., Suter, T., & Krayenbuehl, H. P. (1993) · Circulation · doi:10.1161/01.cir.88.5.2139 · Cited by 142
Membrane protein damage and methylation reactions in chronic renal failure
Perna, A. F., Ingrosso, D., Galletti, P., Zappia, V., & Santo, N. G. D. (1996) · Kidney International · doi:10.1038/ki.1996.324 · Cited by 62
L-arginine for testing endothelium-dependent vascular functions in health and disease.
Giugliano, D., Marfella, R., Verrazzo, G., Acampora, R., Nappo, F., Ziccardi, P., Coppola, L., & D'Onofrio, F. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.3.e606 · Cited by 52
Self-citationGiugliano, D., Marfella, R., Verrazzo, G., et al. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-5-199509010-00003 · Cited by 33
Cited by
Effect of Lifestyle Changes on Erectile Dysfunction in Obese Men: A Randomized Controlled Trial
Esposito, K., Giugliano, F., Di Palo, C., Giugliano, G., Marfella, R., D'Andrea, F., D'Armiento, M., & Giugliano, D. (2004) · JAMA · doi:10.1001/jama.291.24.2978 · Cited by 841
“Endothelial function was assessed with the L-arginine test, as previously described.(14) Briefly, an intravenous bolus of 3 g of L-arginine (10 mL of a 30% solution of L-arginine monochloride), the natural precursor of nitric oxide, was injected intravenously within 60 seconds.”
MethodThe controversy over homocysteine and cardiovascular risk
Ueland, P. M., Refsum, H., Beresford, S. A., & Vollset, S. E. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.2.324 · Cited by 517
Endothelial function and coronary artery disease
Kinlay, S., Libby, P., & Ganz, P. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200108000-00003 · Cited by 384
Walsh, B. W., Paul, S., Wild, R. A., Dean, R. A., Tracy, R. P., Cox, D. A., & Anderson, P. W. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.1.6326 · Cited by 326
Potential Antiatherogenic Mechanisms of Ascorbate (Vitamin C) and α-Tocopherol (Vitamin E)
Carr, A. C., Zhu, B.-Z., & Frei, B. (2000) · Circulation Research · doi:10.1161/01.res.87.5.349 · Cited by 304
Metadata
- Authors
- Nappo, F.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 1999-06-09
- Volume
- 281
- Issue
- 22
- Pages
- 2113
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2011477467
- Cited by
- 270
- References
- 37
- FWCI
- 16.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.